These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 346541)

  • 1. [The therapy of tinnitus resulting from blast injury (author's transl)].
    Jakobs P; Martin G
    HNO; 1978 Mar; 26(3):104-6. PubMed ID: 346541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of Betahistine Mesilate combined with Flunarizine Hydrochloride for treating tinnitus].
    Ma FR; Xin Y; Zhao YM; Lü JQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Apr; 41(4):269-73. PubMed ID: 16848175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Betahistine treatment of Menière's disease (author's transl)].
    Chüden HG
    Laryngol Rhinol Otol (Stuttg); 1978 Nov; 57(11):997-1007. PubMed ID: 723406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results].
    Jurkiewicz D; Kantor I; Usowski J
    Pol Merkur Lekarski; 2006; 21 Suppl 1():3-12. PubMed ID: 17469244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of sudden deafness with xantinolnicotinate (Complamin) in increasing dosage].
    Halevy A; Strohm G; Wieczorek U
    HNO; 1986 Jul; 34(7):285-90. PubMed ID: 3744912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard) (author's transl)].
    Sérey CT; Saling E
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):283-9. PubMed ID: 7008399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Menière's disease with betahistine (author's transl)].
    Stupp H; Kahl S
    HNO; 1976 Sep; 24(9):320-5. PubMed ID: 965272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of betahistine hydrochloride in the treatment of Ménière's disease.
    Segers JM; Boedts D
    Acta Otorhinolaryngol Belg; 1975; 29(5):814-21. PubMed ID: 1224965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral chemotherapy in tinnitus.
    Kay NJ
    Br J Audiol; 1981 May; 15(2):123-4. PubMed ID: 7225648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences with betahistine].
    Müller H; Buttkus R
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):151-3. PubMed ID: 6602925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Teonicol and trental in the treatment of duodenal ulcer].
    Vorob'ev LP; Samsonov AA; Pivovarova EIa
    Sov Med; 1986; (10):98-100. PubMed ID: 3544244
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of tinnitus: oral treatment with melatonin and sulodexide.
    Neri G; Baffa C; De Stefano A; Poliandri A; Kulamarva G; Di Giovanni P; Petrucci AG; Castriotta A; Citraro L; Cerrone D; D' Orazio F; Croce A
    J Biol Regul Homeost Agents; 2009; 23(2):103-10. PubMed ID: 19589291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator and vitamins in therapy of sensorineural hearing loss following war-related blast injury: retrospective study.
    Sprem N; Branica S; Dawidowsky K
    Croat Med J; 2001 Dec; 42(6):646-9. PubMed ID: 11740848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the oxidative glucose brain metabolism under long-term xantinol-nicotinate medication (author's transl)].
    Quadbeck H; Lehmann E
    Arzneimittelforschung; 1978; 28(9):1531-2. PubMed ID: 582552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of a programmed release preparation of betahistine mesylate in the treatment of Ménière's disease (author's transl)].
    Pialoux P
    Ann Otolaryngol Chir Cervicofac; 1981; 98(9):483-6. PubMed ID: 7041769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol in the treatment of tinnitus: a double-blind study.
    Yilmaz I; Akkuzu B; Cakmak O; Ozlüoglu LN
    Otolaryngol Head Neck Surg; 2004 May; 130(5):604-10. PubMed ID: 15138428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.